1. Clear cell renal cell carcinoma molecular variations in non‐Hispanic White and Hispanic patients
- Author
-
Ken Batai, Yuliang Chen, Brenna A. Rheinheimer, Amit Arora, Ritu Pandey, Ronald L. Heimark, Erika R. Bracamonte, Nathan A. Ellis, and Benjamin R. Lee
- Subjects
gene expression and diversity Hispanics and European Americans (comparison) ,health disparities ,molecular subtype ,VHL ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background The United States is becoming increasingly diverse, but few molecular studies have assessed the progression of clear cell renal cell carcinoma (ccRCC) in diverse patient populations. This study examined ccRCC molecular variations in non‐Hispanic White (NHW) and Hispanic patients and their effect on the association of gene expression with high‐grade (Grade 3 or 4) ccRCC and overall mortality. Methods A total of 156 patients were included in VHL sequencing and/or TempO‐Seq analysis. DESeq2 was used to identify the genes associated with high‐grade ccRCC. Logistic regression analysis was performed to assess whether race and ethnicity was associated with high/moderate impact VHL somatic mutations and the ccA/ccB subtype. Cox regression analysis was performed to assess association of molecular subtype and gene expression with overall mortality. Results NHWs had moderate or high impact mutations in the VHL gene at a higher frequency than Hispanics (40.2% vs. 27.4%), while Hispanics had a higher frequency of the ccA subtype than NHWs (61.9% vs. 45.8%). ccA was more common in patients with BMI≥35 (65.2%) than in those with BMI
- Published
- 2023
- Full Text
- View/download PDF